Catalog |
name |
Description |
price |
R-R-4138 |
CB2 receptor agonist 2 CAS No.1314230-75-5 |
CB2 receptor agonist 2/CAS No.1314230-75-5 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor with a Ki of 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2. |
price> |
R-R-4139 |
PSB-SB-487 CAS No.1399049-81-0 |
PSB-SB-487/CAS No.1399049-81-0 is a potent GPR55 antagonist and CB2 agonist with an IC50 value of 0.113 µM for GPR55, and a Ki value of 0.292 µM for human CB2. PSB-SB-487 can be used for researching diabetes, Parkinson’s disease, neuropathic pain, and cancer. |
price> |
R-R-4140 |
CB2 receptor agonist 3 CAS No.919077-81-9 |
CB2 receptor agonist 3/CAS No.919077-81-9 is a robust and selective CB2 cannabinoid agonist with Kis of 7.6 and 900 nM for CB2 and CB1, respectively. CB2 receptor agonist 3 significantly increases P-ERK 1/2 expression in HL-60 cells. |
price> |
R-R-4141 |
(Rac)-Zevaquenabant CAS No.1610420-28-4 |
(Rac)-Zevaquenabant ((Rac)-MRI-1867/CAS No.1610420-28-4, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-Zevaquenabant is potential for the research of liver fibrosis. |
price> |
R-R-4142 |
N-Arachidonyldopamine CAS No.199875-69-9 |
N-Arachidonyldopamine/CAS No.199875-69-9 is a potent and selective endogenous CB1 receptor agonist with a Ki of 250 nM. N-Arachidonyldopamine is also a potent and selective TRPV1 agonist an with EC50 of ~ 50 nM. |
price> |
R-R-4143 |
CB2R/FAAH modulator-2 CAS No.2876918-68-0 |
CB2R/FAAH modulator-2 (compound 26)/CAS No.2876918-68-0 is a dual targeting modulator that acts as a CB2R agonist and FAAH inhibitor. The Ki values for CB2R/FAAH modulator-2 are 10.8 and 152.9 nM for CB2R and CB1R, respectively, and the IC50 value for FAAH is 6.2 μM. CB2R/FAAH modulator-2 can be used in studies related to cancer, deleterious inflammatory cascades occurring in neurodegenerative diseases, and COVID-19 infection. |
price> |
R-R-4144 |
CB1R antagonist 1 CAS No.334668-69-8 |
CB1R Allosteric modulator 5/CAS No.334668-69-8, a selective cannabinoid-1 receptor (CB1R) inverse agonist with an IC50 value of 4.2 μM and EC50 value of >10 μM. CB1R Allosteric modulator 5 can be used for the research of metabolic and obesity. |
price> |
R-R-4145 |
BMS-646256 CAS No.464213-10-3 |
BMS-646256/Ibipinabant/SLV319/CAS No.464213-10-3 is a potent, selective and orally active antagonist of cannabinoid CB1 receptor, with a Ki of 7.8 nM. Ibipinabant shows more than 1000-fold selectivity for CB1 over CB2 (Ki=7943 nM). Ibipinabant can be used for the research of obesity and diabetic. |
price> |
R-R-4146 |
NIDA-41020 CAS No.502486-89-7 |
NIDA-41020/CAS No.502486-89-7 is a potent and selective cannabinoid receptor 1(CB1) antagonist with a Ki of 4.1 nM. NIDA-41020 was designed as a potential radioligand for use in positron emission tomography (PET). |
price> |
R-R-4147 |
MJ15 CAS No.944154-76-1 |
MJ15/CAS No.944154-76-1 is a potent and selective CB1 receptor antagonist with a Ki of 27.2 pM and an IC50 of 118.9 pM for rat CB1 receptors. MJ15 exhibits potency in obesity and hyperlipidemia models. MJ15 inhibits food intake and increases in body weight in diet-induced obese rats and mice. |
price> |